Christopher J. Warren, M.D. (@cjwarren_mayoaz) 's Twitter Profile
Christopher J. Warren, M.D.

@cjwarren_mayoaz

@MayoUrology AZ PGY-4 via Rutgers-NJMS. Outdoor enthusiast. Husband, father

ID: 987769335233110018

calendar_today21-04-2018 19:05:36

1,1K Tweet

816 Followers

1,1K Following

Dutch Rojas (@dutchrojas) 's Twitter Profile Photo

If you’re a physician in private practice, your student debt doesn’t count. Not to the federal government. Not to PSLF. Not if you built your own clinic, serve your own patients, and operate without subsidies. But if you work for a tax-exempt system that receives billions in

Christopher J. Warren, M.D. (@cjwarren_mayoaz) 's Twitter Profile Photo

Nice to have guidelines for a difficult to treat condition! I have found diagnostic cord block to be particularly useful in this population

Rashid K. Sayyid (@rksayyid) 's Twitter Profile Photo

#AUA25 EMBARK: T recovery (≥175 ng/dL) following treatment suspension at Week 37 📌Enza + ADT: 84% full, median time to T recovery: 8.3 mo 📌 ADT only: 88%, 6 mo 📌Only 1-2% had no recovery (11-15% partial recovery) 📌Superior T recovery in <70 yr pts (89% vs 78%, 92% vs 84%)

Sia Daneshmand, M.D. (@siadaneshmand) 's Twitter Profile Photo

Extremely valuable study to help us counsel patients. Radical cystectomy still has major role in management of aggressive #NMIBC. Congratulations John Gore and Angie Smith on completing this important trial. Looking forward to part II! Bladder Cancer Advocacy Network IBCG

UroToday.com (@urotoday) 's Twitter Profile Photo

Who still needs a lymph node dissection with a negative PSMA-PET? Results from the Michigan Urological Surgery Improvement Collaborative. Presented by Ana Moser, MD Wayne State University School of Medicine. Written coverage by Julian Chavarriaga University of Toronto > bit.ly/44KHRhz MUSIC Urology Amer. Urol. Assn.

Who still needs a lymph node dissection with a negative PSMA-PET? Results from the Michigan Urological Surgery Improvement Collaborative. Presented by Ana Moser, MD <a href="/waynemedicine/">Wayne State University School of Medicine</a>. Written coverage by <a href="/chavarriagaj/">Julian Chavarriaga</a> <a href="/UofT/">University of Toronto</a> &gt; bit.ly/44KHRhz <a href="/MUSICUrology/">MUSIC Urology</a> <a href="/AmerUrological/">Amer. Urol. Assn.</a>
Ed Gaines (@edgainesiii) 's Twitter Profile Photo

For clinicians and those in the physician advocacy community, the next several weeks &/or months could be "make or break" time to reverse the -2.83% Medicare cut & add a permanent inflationary adjustment to the Medicare physician fee schedule (MPFS). Key members of the US

For clinicians and those in the physician advocacy community, the next several weeks &amp;/or months could be "make or break" time to reverse the -2.83% Medicare cut &amp; add a permanent inflationary adjustment to the Medicare physician fee schedule (MPFS).  

Key members of the US
Rachel S. Rubin, MD (@drrachelrubin) 's Twitter Profile Photo

How to write the prescriptions Check out the new guideline for genitourinary syndrome of menopause Endorsed by urologists, urogynecologists, menopause and sexual health specialists auanet.org/guidelines-and…

How to write the prescriptions 

Check out the new guideline for genitourinary syndrome of menopause 

Endorsed by urologists, urogynecologists, menopause and sexual health specialists 

auanet.org/guidelines-and…
Anders Gilberg (@andersgilberg) 's Twitter Profile Photo

Today Dr. Roger Marshall introduced S. 1640 the ‘‘Medicare Patient Access and Practice Stabilization Act of 2025’’ which would increase Medicare physician reimbursement by 8.51% starting June 1. The increase reflects a prorated reversal of the 2.83% Medicare cut physician practices

Today <a href="/RogerMarshallMD/">Dr. Roger Marshall</a> introduced S. 1640 the ‘‘Medicare Patient Access and Practice Stabilization Act of 2025’’ which would increase Medicare physician reimbursement by 8.51% starting June 1. The increase reflects a prorated reversal of the 2.83% Medicare cut physician practices
Brad Carper (@hortonbrospharm) 's Twitter Profile Photo

Prescription for Pomalyst, a medication used to treat multiple myeloma. Humana Medicare Part-D paid us -$1,438.26 under the cost of the drug. In other words, my pharmacy has to spend $23,971 just to wait 4-6 weeks for insurance reimbursement to lose -$1,438.26. We can't even

Prescription for Pomalyst, a medication used to treat multiple myeloma. 

<a href="/Humana/">Humana</a> Medicare Part-D paid us -$1,438.26 under the cost of the drug. In other words, my pharmacy has to spend $23,971 just to wait 4-6 weeks for insurance reimbursement to lose -$1,438.26.

We can't even
Robert Berry, DO (@txsportsdoc) 's Twitter Profile Photo

More unconscionable behavior from UHC. Placing their own nurse practitioners in nursing homes to deny care and hospital transfers. Enrolling demented pts into Advantage plans without their knowledge to capture more Federal dollars and paying bonuses(sorry, shared savings) for

Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Update letter from Merck on TICE BCG timed for #ASCO25 “We are on track to complete the project on time and expect our plant to open by late 2026 ... facility is expected to triple our TICE BCG manufacturing capacity … meet the needs of physicians and patients for the

Update letter from <a href="/Merck/">Merck</a> on TICE BCG timed for #ASCO25 
“We are on track to complete the project on time and
expect our plant to open by late 2026 ... facility is expected to triple our TICE BCG manufacturing capacity … meet the needs of physicians and patients for the
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

The most practice changing trial from #ASCO25 is now live on <a href="/NEJM/">NEJM</a> .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. 
Perfect case example of a #cancergroundshot trial.
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25
JAMA (@jama_current) 's Twitter Profile Photo

Caring for surgical patients requires skill both in and out of the operating room. Attention to 3 core communication skills offers a way for surgeons to collaborate with patients and families to make patient-centered decisions about surgery. ja.ma/43VCOdm

BAUS (@bausurology) 's Twitter Profile Photo

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside Prostate Cancer UK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via The Times and The Sunday Times: thetimes.com/uk/healthcare/…

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ 

We, alongside <a href="/ProstateUK/">Prostate Cancer UK</a>, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer

Via <a href="/thetimes/">The Times and The Sunday Times</a>: thetimes.com/uk/healthcare/…